Landiolol Completed Phase 3 Trials for Coronary Artery Disease Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT00924586Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)